Objective:

To highlight the importance of optimizing next-generation sequencing (NGS) workflows in precision oncology to improve efficiency and scalability.

Key Findings:

• The Oncomine Dx Express Test reduced turnaround time by 62 hours compared to the hybrid-capture workflow.
• Total turnaround time for the Oncomine Dx Express Test was 26.8 hours, while the hybrid-capture system took 88.9 hours.
• The Oncomine Dx Express Test required only 41 minutes of hands-on time, compared to 451 minutes for the hybrid-capture workflow.

Interpretation:

Redesigning NGS workflows can significantly enhance efficiency, reduce labor costs, and improve turnaround times without sacrificing quality.

Limitations:

• The study was conducted in a single laboratory setting, which may limit generalizability.
• Only two NGS workflows were compared, potentially overlooking other viable options.

Conclusion:

Optimizing NGS workflows through automation and redesign can meet the increasing demands of precision oncology testing effectively.